| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 48 |
| 1 | WARFARIN | 10 |
| 2 | BEVACIZUMAB | 8 |
| 3 | FUROSEMIDE | 8 |
| 4 | DROSPIRENONE AND ETHINYL ESTRADIOL | 7 |
| 5 | HYDROXYUREA | 7 |
| 6 | PREDNISONE | 7 |
| 7 | RUXOLITINIB | 7 |
| 8 | SPIRONOLACTONE | 7 |
| 9 | ACETAMINOPHEN | 6 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 52 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 3 | Loop Diuretic [EPC] | 10 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 5 | Kinase Inhibitor [EPC] | 9 |
| 6 | Benzodiazepine [EPC] | 8 |
| 7 | Factor Xa Inhibitor [EPC] | 8 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 |
| 9 | Aldosterone Antagonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Complement Inhibitor [EPC] | 52 | 0.0009 |
| 3 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 4 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |